Vis enkel innførsel

dc.contributor.authorTaneja, Sunita
dc.contributor.authorChowdhury, Ranadip
dc.contributor.authorKvestad, Ingrid
dc.contributor.authorBhandari, Nita
dc.contributor.authorStrand, Tor Arne
dc.date.accessioned2023-09-15T08:34:25Z
dc.date.available2023-09-15T08:34:25Z
dc.date.created2022-09-16T14:43:49Z
dc.date.issued2022
dc.identifier.citationBritish Journal of Nutrition. 2022, .en_US
dc.identifier.issn0007-1145
dc.identifier.urihttps://hdl.handle.net/11250/3089658
dc.description.abstractFolate and vitamin B12 are essential for growth. Our objective was to estimate their long-term effects on linear growth in North Indian children. This is a follow-up study of a factorial designed, double-blind, randomised, placebo-controlled trial in 1000 young children. Starting at 6–30 months of age, we gave folic acid (approximately 2 RDA), vitamin B12 (approximately 2 RDA), both vitamins or a placebo daily for 6 months. Six years after the end of supplementation, we measured height in 791 children. We used the plasma concentrations of cobalamin, folate and total homocysteine to estimate vitamin status. The effect of the interventions, the association between height-for-age z-scores (HAZ) and baseline vitamin status, and the interactions between supplementation and baseline status were estimated in multiple regression models. Mean (SD) age at follow-up was 7·4 (0·7) years (range 6 to 9 years). There was a small, non-significant effect of vitamin B12 on linear growth and no effect of folic acid. We observed a subgroup effect of vitamin B12 supplementation in those with plasma cobalamin concentration < 200 pmol/l (Pfor interaction = 0·01). The effect of vitamin B12 supplementation in this group was 0·34 HAZ (95 % CI 0·11, 0·58). We found an association between cobalamin status and HAZ in children not given vitamin B12 (Pfor interaction = 0·001). In this group, each doubling of the cobalamin concentration was associated with 0·26 (95 % CI 0·15, 0·38) higher HAZ. Suboptimal vitamin B12 status in early childhood seemingly limits linear growth in North Indian children. © The Author(s), 2022. Published by Cambridge University Press on behalf of The Nutrition Society. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.en_US
dc.description.abstractVitamin B12 and/or folic acid supplementation on linear growth; A 6 years follow-up study of a randomised controlled trial in early childhood in North Indiaen_US
dc.language.isoengen_US
dc.relation.urihttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/9D27A863E0AAAE7EFAD87B01B4BA052F/S0007114522002343a.pdf/vitamin-b12-andor-folic-acid-supplementation-on-linear-growth-a-6-year-f
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleVitamin B12 and/or folic acid supplementation on linear growth; A 6 years follow-up study of a randomised controlled trial in early childhood in North Indiaen_US
dc.title.alternativeVitamin B12 and/or folic acid supplementation on linear growth; A 6 years follow-up study of a randomised controlled trial in early childhood in North Indiaen_US
dc.typePeer revieweden_US
dc.typeJournal articleen_US
dc.rights.holder© The Author(s), 2022en_US
dc.description.versionpublishedVersionen_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode2
dc.identifier.doi10.1017/S0007114522002343
dc.identifier.cristin2052573
dc.source.journalBritish Journal of Nutritionen_US
dc.source.pagenumber8en_US
dc.relation.projectNorges forskningsråd: 172 226en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal